Mark Blagden

Summary

Country: UK

Publications

  1. ncbi Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials
    Oliver Löwenstein
    Schmerzpraxis, Mainz, Germany
    BMC Clin Pharmacol 10:12. 2010
  2. ncbi Efficacy and safety of ezetimibe co-administered with atorvastatin in untreated patients with primary hypercholesterolaemia and coronary heart disease
    M D Blagden
    Avondale Surgery, Chesterfield, UK
    Curr Med Res Opin 23:767-75. 2007

Collaborators

  • Oliver Löwenstein
  • Michael Hopp
  • Petra Leyendecker
  • Björn Bosse
  • Eberhard A Lux
  • Karen Reimer
  • Karen H Simpson

Detail Information

Publications2

  1. ncbi Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials
    Oliver Löwenstein
    Schmerzpraxis, Mainz, Germany
    BMC Clin Pharmacol 10:12. 2010
    ....
  2. ncbi Efficacy and safety of ezetimibe co-administered with atorvastatin in untreated patients with primary hypercholesterolaemia and coronary heart disease
    M D Blagden
    Avondale Surgery, Chesterfield, UK
    Curr Med Res Opin 23:767-75. 2007
    ....